At a glance
What is it—and why does it matter?
In this review’s terminology, “FS-344” is the abbreviation used for the peptide follistatin-344.
Sources for this introduction: [1]
This published profile is a reference in progress. Findings retain their source context; missing topics are marked below.
What is it?
A molecule, not a product name.
Identity
In this review’s terminology, “FS-344” is the abbreviation used for the peptide follistatin-344.
- Source records
- 1
- Independent studies
- 1
Evidence boundary: Applies only to the source-defined population, formulation, dose, and assessment period.
Exact passages, locators, and provenance
- supports · Source-backed record
“FS-344 (follistatin-344)”
Safety and Efficacy of Approved and Unapproved Peptide Therapies for Musculoskeletal Injuries and Athletic Performance. · Abstract
pubmed:41966639:9547b381c1d2:9547b381c1d2
How does it work?
Target, response, and disposition.
This profile does not yet contain a published summary for this topic. This is a coverage gap, not evidence that no research exists.
What has been studied?
What the evidence says.
This profile does not yet contain a published summary for this topic. This is a coverage gap, not evidence that no research exists.
Risks and interactions
Risks, organized for scanning.
This profile does not yet contain a published summary for this topic. This is a coverage gap, not evidence that no research exists.
Products and regulatory status
Same ingredient. Different records.
This profile does not yet contain a published summary for this topic. This is a coverage gap, not evidence that no research exists.
Administration context
The practical clinical context.
This profile does not yet contain a published summary for this topic. This is a coverage gap, not evidence that no research exists.
Research status + gaps
What still needs better answers?
- No publishable claim yet for: administration, contraindication, effect, interaction, mechanism, regulatory, safety
- 1 compiled claim(s) withheld by automated assurance: assurance_score_below_0.72 (1), current_regulatory_source_required (1), extraction_ambiguity (2), high_risk_requires_regulatory_or_two_independent_sources (1), no_direct_support (1)
These are the limits of this profile, not an exhaustive list of scientific uncertainties.
References + discovery
Open the records yourself.
- Safety and Efficacy of Approved and Unapproved Peptide Therapies for Musculoskeletal Injuries and Athletic Performance. ↗
pubmed · published 2026-08-01 · retrieved 2026-08-17T23:10:15Z
Publication history and provenance
Version 2 · Automated assessment · 2026-08-17T23:10:15Z
cb8606d622da2612adb2273f19d382905180b7e0b406665c2a569a0c3de31253